Presymptom Health

Medical Devices & EquipmentSeedLeeds, UKpresymptom.com

Latest round

Seed

Last raised

Mar 2024

Total raised

Undisclosed

Investors

3

About Presymptom Health

Founded in 2019 and based in Leeds, UK, Presymptom Health Limited provides tests for the pre-symptomatic diagnosis of sepsis.  As of 2024, the company is headed by its CEO Dr Iain Miller. The firm engages itself in the development of clinical diagnostic tests and associated clinical decision-support software that helps in the detection of infection and sepsis. The test developed by the firm runs on molecular PCR genomic systems.

Who invested in Presymptom Health

3 investors across 1 round

See all investors in Presymptom Health

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 21, 2024

    Amount

    Undisclosed

    Investors

    Locked

Questions about Presymptom Health

Who invested in Presymptom Health?

Presymptom Health has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Presymptom Health raised?

Presymptom Health has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Presymptom Health last raise money?

Presymptom Health's most recent round on record is a Seed, in Mar 2024.

What does Presymptom Health do?

Founded in 2019 and based in Leeds, UK, Presymptom Health Limited provides tests for the pre-symptomatic diagnosis of sepsis.

Where is Presymptom Health headquartered?

Presymptom Health is headquartered in Leeds, UK.

Which VCs invest in companies like Presymptom Health?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Presymptom Health's stage. Their profiles are linked below.

Raising like Presymptom Health? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.